kynuramine has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TK; Li, W; Lin, Z; Slominski, AT; Tidwell, WJ | 1 |
| Kim, TK; Li, W; Lin, Z; Reiter, RJ; Slominski, AT | 1 |
2 other study(ies) available for kynuramine and Skin Neoplasms
| Article | Year |
|---|---|
Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro.
Topics: 5-Methoxytryptamine; Adult; Age Factors; Aged; Aged, 80 and over; Black or African American; Cell Proliferation; Cells, Cultured; Epidermis; Female; Humans; In Vitro Techniques; Kynuramine; Male; Melanocytes; Melanoma; Melatonin; Middle Aged; Protein-Tyrosine Kinases; Sex Factors; Skin Neoplasms; White People | 2015 |
N1-Acetyl-5-Methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Black or African American; Cell Line; Cell Line, Tumor; Cell Proliferation; Epidermis; Female; Humans; In Vitro Techniques; Keratinocytes; Kynuramine; Male; Melanocytes; Melanoma; Melatonin; Middle Aged; Skin Neoplasms; White People | 2015 |